Association Between Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19 Infection and Rates of Hospital Readmission and Mortality

IMPORTANCE: Current guidelines recommend use of dexamethasone, 6 mg/d, up to 10 days or until discharge for patients hospitalized with COVID-19. Whether patients who received less than 10 days of corticosteroids during hospitalization for COVID-19 benefit from continuing treatment at discharge has n...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Cheng-Wei, Yu, Albert S., Song, Hubert, Park, Joon S., Wu, Stefanie S., Khang, Vang Kou, Subject, Christopher C., Shen, Ernest
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905383/
https://www.ncbi.nlm.nih.gov/pubmed/35258575
http://dx.doi.org/10.1001/jamanetworkopen.2022.1455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905383/
https://www.ncbi.nlm.nih.gov/pubmed/35258575
http://dx.doi.org/10.1001/jamanetworkopen.2022.1455

Ejemplares similares